Moderna Wednesday announced it will soon request Emergency Use Authorization for its pediatric COVID vaccine. The company said the majority of COVID cases observed during its pediatric clinical trials were mild, making it impossible to detect the vaccine’s protective effect against the worst outcomes.
VAERS data released today by the Centers for Disease Control and Prevention included a total of 965,843 reports of adverse events from all age groups following COVID vaccines, including 20,244 deaths and 155,506 serious injuries between Dec. 14, 2020, and Dec. 10, 2021.
In an exclusive interview with The Defender, Amy Bolin said in order to be approved for a double-lung transplant, her husband had to be fully vaccinated for COVID even though he’d had the virus and recovered. After his second Moderna shot, he developed a pulmonary embolism and heart condition and died before he could get new lungs.
Citing concerns about the risk of heart inflammation associated with the vaccines, the U.S. Food and Drug Administration asked Pfizer and Moderna to expand the number of children in their clinical trials.
A group of 27 prominent health experts and scientists are inviting public comment on their petition calling on the FDA to withhold full approval of COVID vaccines until efficacy and safety measures are met.